Important pharmacy news and late-breaking industry information updated daily.
The Ohio Pharmacists Association (OPA) recently launched a new initiative to expand pharmacist services across the state. The effort comes on the heels of SB 265, a new state law signed by former Gov. John Kasich in April 2019 that formally recognized pharmacists as providers throughout the state insurance code.
Initiation of statin therapy during childhood in patients with familial hypercholesterolemia slowed the progression of carotid intima–media thickness and reduced the risk of cardiovascular disease in adulthood, according to a new study published in the New England Journal of Medicine that examined the long-term effect of statin therapy in children.
National Prescription Drug Take Back Day is this Saturday, October 26. The event, held each spring and fall since it was enacted by DEA in 2014, is an opportunity for people in cities throughout the United States to safely dispose of prescription drugs, including opioids, in authorized disposal sites in their communities—including those placed in pharmacies.
Monday's $260 million settlement between four drug companies and two Ohio counties clears the way for broader talks aimed at resolving thousands of opioid-addiction cases nationwide. For now, the deal will direct $215 million to Ohio's Cuyahoga and Summit counties from drug distributors McKesson, Cardinal Health, and AmerisourceBergen.
Talks to settle lawsuits involving the opioid epidemic appeared to be at a standstill on Sunday, just a day before the trial is set to begin.
Older adults are taking more psychoactive medications than they did in years past, according to researchers who wanted to find out how prevalent psychoactive medication use is in this patient population.
California officials have invalidated more than 1,000 pharmacists' test scores because of cheating on a state exam, a move that has caused an uproar among pharmacists who say they have lost wages and job opportunities as a result.
Drug distributors AmerisourceBergen, Cardinal Health, and McKesson Corporation, as well as manufacturers Johnson & Johnson and Teva, have reportedly agreed with multiple states on a framework to resolve thousands of opioid cases with a settlement worth approximately $50 billion in cash and addiction treatments.
Three major drug distributors—McKesson, AmerisourceBergen, and Cardinal Health—are reportedly in negotiations to pay $18 billion to settle litigation brought by state and local governments blaming them for fueling the opioid crisis.
California became the first state to authorize pharmacists to dispense HIV prevention medications, including both pre-exposure prophylaxis (PrEP) and postexposure prophylaxis (PEP), without a physician’s prescription. The groundbreaking legislation was made official on October 7 after Gov. Gavin Newsom signed into law SB 159.